Breo Ellipta (fluticasone furoate/vilanterol)

pCPA File Number: 20883
Negotiation Status:
Concluded with an LOI
Indication(s):
Asthma
Sponsor/Manufacturer:
GlaxoSmithKline Inc.
CDA-AMC Project Number:
SR0442-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: